1809325-45-8: Lurasidone Sulfoxide

It is one of impurity present in Lurasidone, Lurasidone is an atypical antipsychotic that is a D2 and 5-HT2A mixed serotonin and dopamine activity to improve cognition, antagonism of serotonin receptors can improve negative symptoms of psychoses and reduce the side effects that are often associated with typical antipsychotics. which is used to treat schizophrenia and depressive episodes associated with bipolar I disorder.

Additional information on CAS 1809325-45-8

Catalogue No.

VE007013

CAS No.

1809325-45-8

Molecular Formula

C28H36N4O3S

Molecular Weight

508.68 g/mol

Parent drug

Lurasidone

IUPAC Name

(3aR, 4S, 7R, 7aS)-2-{(1R, 2R)-2-[4-(1-Oxido-1, 2-benzisothiazol-3-yl)piperazin-1-yl methyl] cyclohexylmethyl}hexahydro-4, 7-methano-2H-isoindole-1, 3-dione

Synonyms

N/A

References

Cruz, M. P. (2011). Lurasidone HCl (Latuda), an Oral, Once-Daily Atypical Antipsychotic Agent for the Treatment of Patients with Schizophrenia. P & T : A Peer-Reviewed Journal for Formulary Management, 36(8), 489–492. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171824/

Status

In-stock